Chrissy Metz opened up about the secrets behind her 100-pound weight loss while addressing Ozempic and gastric bypass surgery rumors. The This Is Us alum, 44, said she’s become “consistent ...

Prescription weight loss medications, including GLP-1 agonists, orlistat, and Contrave, may be effective for some people. But other lifestyle changes are still necessary for long-term success.

Rapper and pop music sensation Lizzo has been on a major weight loss journey over the past several months, and she showed off her stunning body transformation in a tight red dress at a red carpet ...

HYDERABAD, April 7 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better compete with ...

One solution some policymakers may try is restricting the number of people on Medicaid who can use the pricey diabetes drugs for weight-loss purposes. Pennsylvania's Medicaid coverage of the drugs ...

The best supplements for weight loss men use, like PhenGold, may just be what you need to give you a little push, and the market has unique products designed to meet your unique goals. Whether you ...

Weight loss journey demands the right kind of diet, lifestyle changes and a workout regimen that can help in faster fat loss and also simultaneously help in building muscles. Mahtab Ekay ...

Weight loss wasn't my main goal, I just wanted to feel better in my body again. I knew that yoga's holistic focus would help me get there, so I didn't have to focus on the scale. Now, my weight ...

This essential building block does far more than just help fitness enthusiasts build muscle – it’s a multifaceted nutrient that could be the missing piece in your weight loss puzzle.

Weight loss drugs, such as those containing GLP-1 agonists like Wegovy and Mounjaro, have emerged as effective tools for people struggling to lose weight. These drugs reduce appetite and sometimes ...

The European Medicines Agency (EMA) has concluded a review of the weight loss drug naltrexone/bupropion (Mysimba), which was prompted by concerns about potential long-term cardiovascular risks.